High FGF‐21 level in a cohort of 22 patients with Dravet Syndrome—Possible relationship with the disease outcomes

High FGF‐21 level in a cohort of 22 patients with Dravet Syndrome—Possible relationship with the disease outcomes

Abstract Objective Dravet syndrome (DS) is a severe and intractable form of epilepsy with prolonged seizures which may evolve to other seizure types and associated with mild‐to‐severe intellectual disabilities. Fibroblast growth factor 21 (FGF‐21) is a stress hormone mediating metabolic and oxidativ...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Anna Ka‐Yee Kwong, Virginia Chun‐Nei Wong, Sheila Suet‐Na Wong, Vanessa Loi‐Yan Chu, Saskia Koene, Jan Smeitink, Cheuk‐Wing Fung
Format: article
Langue:EN
Publié: Wiley 2021
Sujets:
dravet syndrome
epileptic encephalopathy
FGF‐21
fibroblast growth factor 21
mitochondrial oxidative phosphorylation
valproate
Neurology. Diseases of the nervous system
RC346-429
Accès en ligne:https://doaj.org/article/ade30fff07e044ef82b2ff57c48f25fe
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/ade30fff07e044ef82b2ff57c48f25fe

Documents similaires